Enrichment and channeling of pluripotent cells by protein nanoparticles
OwnerRichard C.K. Yeninventor
Life of this patent
Estimating the term…
Abstract
Fibrinogen-coated Albumin Nanospheres (FAS) has shown that it can mobilize bone marrow cells into the blood which then go to injured soft and hard tissues to achieve accelerated repair. It is hypothesize that (a) brain injuries caused by low-dose irradiation under simulated microgravity can be mitigated by the administration of FAS; and (b) the mechanism is from acceleration of neo-vascularization, proven by lineage study of GFP-labeled bone marrow cells implanted into compatible non-GFP animals before injury, which regenerate into functional GFP-brain cells after FAS treatment.
Claims20
A method of using an albumin nanoparticle suspension containing submicron albumin spheres to enrich and channel pluripotent cells in a subject in need thereof, the method comprising the step of administering intravenously a therapeutically effective amount of the albumin nanoparticle suspension containing the submicron albumin spheres to the subject, the albumin spheres being configured to provide acceleration of in vivo neo-vascularization of the pluripotent cells to enrich one or more of the pluripotent cells into desirable cells for proper physiological function and to channel the one or more enriched pluripotent cells so the enriched pluripotent cells are reprogrammed to differentiate into pathways useful to the subject.
A method of using an albumin nanoparticle suspension containing submicron albumin spheres to enrich and channel pluripotent cells in a subject in need thereof, the method comprising the steps of:
- a) providing a suspension including fibrinogen-coated albumin nanospheres prepared by coating blank albumin spheres with a solution containing human fibrinogen;
- b) administering intravenously a therapeutically effective amount of the albumin nanoparticle suspension to the subject;
- c) enriching one or more of the pluripotent cells into desirable cells for proper physiological function by in vivo neo-vascularization of the one or more pluripotent cells;
- and
- d) channeling the one or more enriched pluripotent cells so the enriched pluripotent cells are reprogrammed to differentiate into pathways useful to the subject.
Dependencies are inferred from the claim text.